Korea Otsuka Pharmaceutical Co., Ltd.
🇰🇷South Korea
Clinical Trials
42
Active:1
Completed:33
Trial Phases
4 Phases
Phase 1:7
Phase 2:3
Phase 3:8
+1 more phases
Drug Approvals
15
PHILIPPINES:15
Drug Approvals
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Phase 4
12 (40.0%)Phase 3
8 (26.7%)Phase 1
7 (23.3%)Phase 2
3 (10.0%)Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
Not yet recruiting
- Conditions
- Tuberculosis, Multidrug-Resistant
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 222
- Registration Number
- NCT06674291
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
Recruiting
- Conditions
- Chronic GastritisAcute Gastritis
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 600
- Registration Number
- NCT05048069
- Locations
- 🇰🇷
Soon Chun Hyang University Hospital Seoul, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
Phase 3
Completed
- Conditions
- Acute GastritisChronic Gastritis
- Interventions
- Drug: MCT-SR
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 392
- Registration Number
- NCT04189705
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of
To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04150172
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, Korea, Republic of
To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04150146
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Bundang, Gyeonggi-do, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found